Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

COHERUS ONCOLOGY INC (CHRS)

128 + Investors. Track Smart Money conviction in CHRS. See who's accumulating, reducing, or initiating positions.

Fetching live quote...
Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +16
Streak
2Q ▲
Buyers last Q
59%

Smart Money Signals — CHRS

Based on 126 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added CHRS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
📊

High ownership — 81% of 3.0Y peak

81% of all-time peak
126 funds currently hold this stock — 81% of the 3.0-year high of 156 funds (reached 2023 Q3). Ownership is elevated but not yet at maximum concentration. Room to grow, but watch if the trend reverses.
📶

Steady growth — +5% more funds vs a year ago

fund count last 6Q
+6 new funds entered over the past year (+5% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 59% buying

68 buying47 selling
Last quarter: 68 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
📈

More new buyers each quarter (+7 vs last Q)

new funds entering per quarter
Funds opening a new CHRS position: 13 → 13 → 21 → 28. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

63% of holders stayed for 2+ years

63% conviction (2yr+) 21% medium 16% new
79 out of 126 hedge funds have held CHRS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares -2%, value -99%

Value
-98%
Shares
-1%
Last quarter: funds added -2% more shares while total portfolio value only changed -99%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
🚀

Acceleration phase — new buyers rushing in

27 → 13 → 13 → 21 → 28 new funds/Q
New funds entering each quarter: 13 → 13 → 21 → 28. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 63% of holders stayed 2+ years

63% veterans 16% 1-2yr 21% new
Of 128 current holders: 81 (63%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
🏆

Elite ownership — 46% AUM from top-100 funds

46% from top-100 AUM funds
26 of 126 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in CHRS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
2.5
out of 10
Low Exit Risk
Exit risk score 2.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — CHRS

In 2025 Q4, 68 hedge funds were net buyers of CHRS (28 opened a new position, 40 added to an existing one), while 47 reduced or exited (35 trimmed, 12 sold completely) — a 59% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. 46% of total institutional value in CHRS is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +16 funds (more new holders than closures). Total institutional holders: 126.

Hedge Fund Ownership: CHRS

How many hedge funds hold CHRS — quarterly history vs. share price
Quarterly hedge fund ownership of CHRS vs. share price

Market Analysis: CHRS

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: CHRS

Healthcare Biotechnology

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

28 top-rated funds 1 high-conviction
Consensus
6.3
/ 10
breadth
×
Elite
0.7
/ 10
conviction
Hedge Fund Positioning: CHRS
2026 Q1 Stats Unlock in 8 days 128 + Investors

Track Smart Money conviction in CHRS. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 128 116 10.34%
13F Shares 51M 52M -1.6%
Total Value $73M $5.01B -98.55%
New Positions 28 21 +7
Increased Positions 42 43 -1
Closed Positions 13 20 -7
Reduced Positions 39 38 +1
Total Calls 2 5 -60.0%
Total Puts 1 1 -
PUT/CALL Ratio 0.5 0.2 Bullish

Statistics: CHRS

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

128 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in CHRS. Verified SEC 13F-HR filings.

Top 25 institutional holders of CHRS — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 CM Management, LLC 2.97% 2,100,000 $3.5M
2 C WorldWide Group Holding A/S 0.07% 1,928,464 $3K
3 Tyche Wealth Partners LLC 0.06% 240,868 $407K
4 GSA CAPITAL PARTNERS LLP 0.03% 319,655
5 Wealth Group, Ltd. 0.02% 14,195
6 Providence Wealth Advisors, LLC 0.02% 15,000 $26K
7 Endowment Wealth Management, Inc. 0.01% 11,521 $19K
8 Simplify Asset Management Inc. 0.01% 253,140 $428K
9 INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC 0.01% 42,408 $74K
10 SteelPeak Wealth, LLC 0.00% 69,000 $117K
11 China Universal Asset Management Co., Ltd. 0.00% 26,525 $45K
12 Bronte Capital Management Pty Ltd. 0.00% 19,282 $33K
13 Jefferies Financial Group Inc. 0.00% 252,000 $426K
14 Medallion Wealth Advisors, LLC 0.00% 6,000 $5K
15 STRS OHIO 0.00% 324,000 $548K
16 Diversified Trust Co 0.00% 38,471 $65K
17 Pallas Capital Advisors LLC 0.00% 11,545 $20K
18 Atria Investments, Inc 0.00% 37,391 $63K
19 INTECH INVESTMENT MANAGEMENT LLC 0.00% 28,100 $47K
20 VANGUARD FIDUCIARY TRUST CO 0.00% 949,919 $1.6M
21 Police & Firemen's Retirement System of New Jersey 0.00% 28,230 $48K
22 Stratos Wealth Partners, LTD. 0.00% 16,131 $27K
23 VANGUARD CAPITAL MANAGEMENT LLC 0.00% 5,452,762 $9.2M
24 Avion Wealth 0.00% 660
25 Cambridge Investment Research Advisors, Inc. 0.00% 43,576
Investor Ownership
History
% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — COHERUS ONCOLOGY INC (CHRS)

What does the Smart Money Trend signal show for CHRS?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added CHRS than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for CHRS?

Slight buying edge — 59% buying: Last quarter: 68 funds bought or added vs 47 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for CHRS holders?

Elite ownership — 46% AUM from top-100 funds: 26 of 126 holders are among the 100 largest funds by AUM, controlling 46% of total institutional value in CHRS. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held CHRS?

63% of holders stayed for 2+ years: 79 out of 126 hedge funds have held CHRS for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.